PepGen Ltd (PEPG) Stock Analysis

PepGen Ltd (PEPG) is a publicly traded company in the HEALTHCARE sector. It trades at $1.45, carries a market capitalization of $102.45M. This page summarizes the public market data, fundamentals, and frequently asked questions for PEPG, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.45
• Market Cap: $102.45M
• EPS: $-1.46
• 52-Week High: $7.80
• 52-Week Low: $1.01

Market Sentiment

PepGen Ltd currently has a Bullish sentiment score of 0.26.

About PepGen Ltd

PepGen Ltd is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, committed to developing cutting-edge oligonucleotide therapeutics targeting severe neurological and neuromuscular diseases. The company's robust pipeline illustrates its innovative approach and its potential to significantly advance treatment options in areas with high unmet medical needs. By leveraging its proprietary technologies and focusing on precision medicine, PepGen is poised to deliver tra...

GNG Research Analysis

GNG Research scores PepGen Ltd (PEPG) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PEPG.

Frequently Asked Questions

Does PEPG pay dividends?

PepGen Ltd (PEPG) does not currently pay a regular dividend.

What is PEPG's market cap?

PepGen Ltd (PEPG) has a market capitalization of $102.45M with a current stock price of $1.45.